Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Press release

BioStock: Iconovo establishes Nordic pharmaceutical sales

Iconovo

Iconovo has started building up the subsidiary Iconovo Pharma, which will sell and market pharmaceuticals in the Nordic region. Inhalation products are a natural focus area for Iconovo Pharma, but they may also consider including other products if both the product and business model are attractive. The portfolio will consist of in-licensed, complex generic products and proprietary inhalation products. The first proprietary product in the portfolio is expected to be a generic equivalent of AstraZeneca's blockbuster Symbicort Turbuhaler. BioStock contacted Fredrik Radencrantz, Director Business Development, to find out more about the plans for Iconovo Pharma.

Read the full article at biostock.se:

https://www.biostock.se/en/2022/12/iconovo-establishes-nordic-pharmaceutical-sales/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.